Evidence map›Paper›PMID 24362107›Full record

ArticleThe Journal of biological chemistry2014

Apelin attenuates oxidative stress in human adipocytes.

Aung Than, Xiaohong Zhang, Melvin Khee-Shing Leow, Chueh Loo Poh, Seow Khoon Chong, Peng Chen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. A Novel Marker in Hypogonadal Hypogonadism: Apelin.Sisli Etfal Hastanesi tip bulteni · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. The Yin and Yang Effect of the Apelinergic System in Oxidative Stress.International journal of molecular sciences · 2023
    Review
  15. Review
  16. Review
  17. A Review of the Roles of Apelin and ELABELA Peptide Ligands in Cardiovascular Disease, Including Heart Failure and Hypertension.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aung ThanFrom the Division of Bioengineering, Nanyang Technological University, 70 Nanyang Drive, Singapore 637457.
Xiaohong Zhang
Melvin Khee-Shing Leow
Chueh Loo Poh
Seow Khoon Chong
Peng Chen
Nanyang Technological University · SGSingapore Institute for Clinical Sciences · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been recently recognized that the increased oxidative stress (ROS overproduction) in obese condition is a key contributor to the pathogenesis of obesity-associated metabolic diseases. Apelin is an adipocytokine secreted by adipocytes, and known for its anti-obesity and anti-diabetic properties. In obesity, both oxidative stress and plasma level of apelin are increased. However, the regulatory roles of apelin on oxidative stress in adipocytes remain unknown. In the present study, we provide evidence that apelin, through its interaction with apelin receptor (APJ), suppresses production and release of reactive oxygen species (ROS) in adipocytes. This is further supported by the observations that apelin promotes the expression of anti-oxidant enzymes via MAPK kinase/ERK and AMPK pathways, and suppresses the expression of pro-oxidant enzyme via AMPK pathway. We further demonstrate that apelin is able to relieve oxidative stress-induced dysregulations of the expression of anti- and pro-oxidant enzymes, mitochondrial biogenesis and function, as well as release of pro- and anti-inflammatory adipocytokines. This study, for the first time, reveals the antioxidant properties of apelin in adipocytes, and suggests its potential as a novel therapeutic target for metabolic diseases.

Indexed as

AdipocytesAntioxidantsApelinApelin ReceptorsCells, CulturedGene Expression Regulation, EnzymologicHumansIntercellular Signaling Peptides and ProteinsMaleMAP Kinase Signaling SystemOxidative StressOxidoreductasesReactive Oxygen SpeciesReceptors, G-Protein-CoupledAntioxidantsApelinApelin ReceptorsAPLN protein, humanAPLNR protein, humanIntercellular Signaling Peptides and ProteinsOxidoreductasesReactive Oxygen SpeciesReceptors, G-Protein-CoupledAdipocyteAdipokinesAntioxidantsOxidative StressReactive Oxygen Species (ROS)

Identifiers

PMID24362107
PMCPMC3916573
OpenAlexW2061575153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.